(NASDAQ: CODX) Co Diagnostics's forecast annual revenue growth rate of 201.95% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Co Diagnostics's revenue in 2025 is $507,892.On average, 4 Wall Street analysts forecast CODX's revenue for 2025 to be $30,092,505, with the lowest CODX revenue forecast at $27,450,376, and the highest CODX revenue forecast at $32,544,040. On average, 4 Wall Street analysts forecast CODX's revenue for 2026 to be $35,775,610, with the lowest CODX revenue forecast at $32,940,451, and the highest CODX revenue forecast at $38,362,327.
In 2027, CODX is forecast to generate $1,067,446,962 in revenue, with the lowest revenue forecast at $1,025,552,866 and the highest revenue forecast at $1,098,806,642.